These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33471653)

  • 1. Understanding Osteoporosis Screening Practices in Men: A Nationwide Physician Survey.
    Choksi P; Gay BL; Reyes-Gastelum D; Haymart MR; Papaleontiou M
    Endocr Pract; 2020 Nov; 26(11):1237-1243. PubMed ID: 33471653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician-Reported Barriers to Osteoporosis Screening: A Nationwide Survey.
    Choksi P; Gay BL; Haymart MR; Papaleontiou M
    Endocr Pract; 2023 Aug; 29(8):606-611. PubMed ID: 37156374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding Worry About Risks Associated With Thyroid Hormone Therapy: A National Survey of Endocrinologists, Family Physicians, and Geriatricians.
    Shah K; Reyes-Gastelum D; Gay BL; Papaleontiou M
    Endocr Pract; 2022 Jan; 28(1):25-29. PubMed ID: 34438052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Requests for Tests and Treatments Impact Physician Management of Hypothyroidism.
    Esfandiari NH; Reyes-Gastelum D; Hawley ST; Haymart MR; Papaleontiou M
    Thyroid; 2019 Nov; 29(11):1536-1544. PubMed ID: 31436135
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of Bone Mineral Density Testing With Risk of Major Osteoporotic Fractures Among Older Men Receiving Androgen Deprivation Therapy to Treat Localized or Regional Prostate Cancer.
    Suarez-Almazor ME; Pundole X; Cabanillas G; Lei X; Zhao H; Elting LS; Lopez-Olivo MA; Giordano SH
    JAMA Netw Open; 2022 Apr; 5(4):e225432. PubMed ID: 35363269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician practices of bone density testing and drug prescribing to prevent or treat osteoporosis during androgen deprivation therapy.
    Tanvetyanon T
    Cancer; 2005 Jan; 103(2):237-41. PubMed ID: 15597384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and management of osteoporosis in men receiving androgen deprivation therapy: a survey of urologists and radiation oncologists.
    Alibhai SM; Rahman S; Warde PR; Jewett MA; Jaffer T; Cheung AM
    Urology; 2006 Jul; 68(1):126-31. PubMed ID: 16844454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with osteoporosis screening and recommendations for osteoporosis screening in older adults.
    Nayak S; Roberts MS; Greenspan SL
    J Gen Intern Med; 2009 May; 24(5):585-91. PubMed ID: 19274478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis and spinal fractures in men with prostate cancer: risk factors and effects of androgen deprivation therapy.
    Diamond TH; Bucci J; Kersley JH; Aslan P; Lynch WB; Bryant C
    J Urol; 2004 Aug; 172(2):529-32. PubMed ID: 15247721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoporosis screening for men: are family physicians following the guidelines?
    Cheng N; Green ME
    Can Fam Physician; 2008 Aug; 54(8):1140-1141, 1141.e1-5. PubMed ID: 18697977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of Screening for Osteoporosis in Older Men With a History of Falls.
    Ito K
    JAMA Netw Open; 2020 Dec; 3(12):e2027584. PubMed ID: 33258906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
    Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
    Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving bone health in men with prostate cancer receiving androgen deprivation therapy: Results of a randomized phase 2 trial.
    Alibhai SMH; Breunis H; Timilshina N; Hamidi MS; Cheung AM; Tomlinson GA; Manokumar T; Samadi O; Sandoval J; Durbano S; Warde P; Jones JM
    Cancer; 2018 Mar; 124(6):1132-1140. PubMed ID: 29211305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a primary care physician workshop on osteoporosis medical practices.
    Laliberté MC; Perreault S; Dragomir A; Goudreau J; Rodrigues I; Blais L; Damestoy N; Corbeil D; Lalonde L
    Osteoporos Int; 2010 Sep; 21(9):1471-85. PubMed ID: 19937428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fracture risk assessment in long-term care: a survey of long-term care physicians.
    Wall M; Lohfeld L; Giangregorio L; Ioannidis G; Kennedy CC; Moser A; Papaioannou A; Morin SN
    BMC Geriatr; 2013 Oct; 13():109. PubMed ID: 24138565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians.
    Tasian GE; Cooperberg MR; Cowan JE; Keyashian K; Greene KL; Daniels NA; Carroll PR; Chan JM
    Urol Oncol; 2012; 30(2):155-60. PubMed ID: 20800514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone health and its correlates in Korean prostate cancer patients receiving androgen deprivation therapy.
    Kim SH; Seong do H; Yoon SM; Choi YD; Song Y; Song H; Choi E
    Eur J Oncol Nurs; 2016 Apr; 21():197-204. PubMed ID: 26522218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy.
    Krupski TL; Smith MR; Lee WC; Pashos CL; Brandman J; Wang Q; Botteman M; Litwin MS
    Cancer; 2004 Aug; 101(3):541-9. PubMed ID: 15274067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoporosis and prostate cancer: a cross-sectional study of Danish men with prostate cancer before androgen deprivation therapy.
    Poulsen MH; Frost M; Abrahamsen B; Brixen K; Walter S
    Scand J Urol; 2014 Aug; 48(4):350-5. PubMed ID: 24548220
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.